Aparasu, RR, Bhatara, V (2005). Antipsychotic prescribing trends among youths, 1997–2002. Psychiatric Services
Aparasu, RR, Bhatara, V (2007). Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004. Current Medical Research and Opinion
Baldwin, D, Kosky, N (2007). Off-label prescribing in psychiatric practice. Advances in Psychiatric Treatment
Barrett, SL, Mulholland, CC, Cooper, SJ, Rushe, TM (2009). Patterns of neurocognitive impairment in first-episode bipolar disorder and schizophrenia. British Journal of Psychiatry
Castro-Fornieles, J, Parellada, M, Soutullo, CA, Baeza, I, Gonzalez-Pinto, A, Graell, M, Paya, B, Moreno, D, de la Serna, E, Arango, C (2008). Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. Journal of Child and Adolescent Psychopharmacology
Cooper, WO, Arbogast, PG, Ding, H, Hickson, GB, Fuchs, DC, Ray, WA (2006). Trends in prescribing of antipsychotic medication for US children. Ambulatory Pediatrics
Cooper, WO, Hickson, GB, Fuchs, C, Arbogast, PG, Ray, WA (2004). New users of antipsychotic medications among children enrolled in TennCare. Archives of Pediatrics & Adolescent Medicine
Doerry, UA, Kent, L (2003). Prescribing practices of community child and adolescent psychiatrists. Psychiatric Bulletin
Hafner, H, Maurer, K, Loffler, W, Fatkenheuer, B, An Der Heiden, W, Riecher-Rossler, A, Behrens, S, Gattaz, WF (1994). The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. The British Journal of Psychiatry. Supplement
Harrison, JL, Cluxton-Keller, F, Gross, D (2012). Antipsychotic medication prescribing trends in children and adolescents. Journal of Pediatric Health Care
Haw, C, Stubbs, J (2010). Off-label psychotropic prescribing for young persons in medium security. Journal of Psychopharmacology
IBM Corp (2010). IBM SPSS Statistics for Macintosh, Version 19.0. Armonk. NY: IBM Corp.
National Institute for Health and Care Excellence (2002
a). Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. TA43. National Institute for Health and Care Excellence: London.
National Institute for Health and Care Excellence (2002
b). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. CG1. National Institute for Health and Care Excellence: London.
Noguera, A, Ballesta, P, Baeza, I, Arango, C, de la Serna, E, Gonzalez-Pinto, A, Parellada, M, Graell, M, Moreno, C, Otero, S, Castro-Fornieles, J (2013). Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability. Journal of Clinical Psychopharmacology
Olfson, M, Blanco, C, Liu, L, Moreno, C, Laje, G (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry
Otasowie, J, Duffy, R, Freeman, J, Hollis, C (2010). Antipsychotic prescribing practice among child psychiatrists and community paediatricians. The Psychiatrist
Paediatric Formulary Committee (2007). British National Formulary for Children 2007. British Medical Association, The Royal Pharmaceutical Society of Great Britain, The Royal College of Paediatrics and Child Health, and The Neonatal and Paediatric Pharmacists Group: London.
Pappadopulos, E, Jensen, PS, Schur, SB, MacIntyre, JC, Ketner, S, Van Orden, K (2002). ‘Real world’ atypical antipsychotic prescribing practices in public child and adolescent inpatient settings. Schizophrenia Bulletin
Pogge, DL, Singer, MB, Harvey, PD (2005). Rates and predictors of adherence with atypical antipsychotic medication: a follow-up study of adolescent inpatients. Journal of Child and Adolescent Psychopharmacology
Rani, F, Murray, ML, Byrne, PJ, Wong, ICK (2008). Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics
Shireman, TI, Olson, BM, Dewan, NA (2002). Patterns of antidepressant use among children and adolescents. Psychiatric Services
Sivaprasad, L, Hassan, T, Handy, S (2006). Survey of atypical antipsychotic use by child and adolescent psychiatrists. Child and Adolescent Mental Health
Stigler, KA, Potenza, MN, Posey, DJ, McDougle, CJ (2004). Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance and management. Paediatric Drugs
Thomas, CR, Holzer, CE (2006). The continuing shortage of child and adolescent psychiatrists. Journal of the American Academy of Child Adolescent Psychiatry
Turkington, A, Mulholland, CC, Rushe, TM, Anderson, R, McCaul, R, Barrett, SL, Barr, RS, Cooper, SJ (2009). Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. British Journal of Psychiatry
Verdoux, H, Tournier, M, Begaud, B (2010). Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatrica Scandinavica
Weller, IVD, Ashby, D, Brook, R, Chambers, MGA, Chick, JD, Drummond, C, Ebmeier, KP, Gunnell, DJ, Hawking, H, Mukaetova-Ladinska, E, O’Tierney, E, Taylor, RJ, York, A
Zwi, M (2004). Report of the CSM expert working group in the safety of selective serotonin reuptake inhibitor antidepressants (http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf). Accessed 22 April 2012.
Whittington, CJ, Kendall, T, Fonaghy, P, Cottrell, D, Cotgrove, A, Boddington, E (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet